Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α
- PMID: 21807114
- DOI: 10.1016/j.biocel.2011.07.007
Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α
Abstract
The mitogen activated protein kinase (MAPK) signaling pathways play significant roles in fundamental cellular processes, such as cell growth and differentiation. It has been shown that the specificity and efficacy of phosphorylation by MAP kinases rely upon distinct MAPK-docking domains (D-domains) found in a wide range of MAPK substrates including the ETS-transcription factor Elk-1. Importantly, the MAPK signaling cascade converges with the hypoxia-induced signaling pathway. The key regulator of hypoxia signaling is the heterodimeric transcription factor hypoxia inducible factor-1 (HIF-1). The α-subunit of HIF-1 (HIF-1α) is a substrate for the ERK2 MAP kinase. Unraveling the interplay of these main signaling systems is a prerequisite for understanding their role in tumor growth, a situation sustained by simultaneous mitogenic and hypoxic signals. In this work, we investigated the molecular cues that direct HIF-1α recognition and phosphorylation by ERK2. We showed that HIF-1α possesses a MAPK docking domain. Utilizing surface plasmon resonance (SPR) methodologies we demonstrated efficient binding between HIF-1α and ERK2, with a K(D) value in the low micromolar range. Although, the D-domain did not contribute to the above interaction significantly, it could act in trans by recruiting ERK2 and conferring responsiveness to poor ERK substrates. These results indicate that, via its conserved D-domain, HIF-1α could serve as a platform for ERK2 in the nucleus of the cell, thus potentially facilitating phosphorylation of other ERK2 substrates. The identification of an ERK2 recognition domain on HIF-1α opens new avenues for the analysis of HIF-1α-related ERK2 signaling and may allow designing of interfering compounds.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.Biochem J. 2003 Mar 15;370(Pt 3):1077-85. doi: 10.1042/BJ20021806. Biochem J. 2003. PMID: 12529172 Free PMC article.
-
Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.Mol Cell Biol. 2001 Jan;21(1):249-59. doi: 10.1128/MCB.21.1.249-259.2001. Mol Cell Biol. 2001. PMID: 11113199 Free PMC article.
-
Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha.J Biol Chem. 2006 Nov 3;281(44):33095-106. doi: 10.1074/jbc.M605058200. Epub 2006 Sep 5. J Biol Chem. 2006. PMID: 16954218
-
Sumoylation of hypoxia inducible factor-1α and its significance in cancer.Sci China Life Sci. 2014 Jul;57(7):657-64. doi: 10.1007/s11427-014-4685-3. Epub 2014 Jun 11. Sci China Life Sci. 2014. PMID: 24916276 Review.
-
Hypoxia-inducible factor-1: A potential pharmacological target to manage psoriasis.Int Immunopharmacol. 2020 Sep;86:106689. doi: 10.1016/j.intimp.2020.106689. Epub 2020 Jun 22. Int Immunopharmacol. 2020. PMID: 32585606 Review.
Cited by
-
Molecular Characterization and Expression Analysis of S6K1 in Cashmere Goats (Capra hircus).Asian-Australas J Anim Sci. 2013 Aug;26(8):1057-64. doi: 10.5713/ajas.2012.12710. Asian-Australas J Anim Sci. 2013. PMID: 25049885 Free PMC article.
-
Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway.Toxicol Sci. 2013 Jul;134(1):26-38. doi: 10.1093/toxsci/kft101. Epub 2013 Jun 7. Toxicol Sci. 2013. PMID: 23748240 Free PMC article.
-
Endostatin exerts radiosensitizing effect in non-small cell lung cancer cells by inhibiting VEGFR2 expression.Clin Transl Oncol. 2016 Jan;18(1):18-26. doi: 10.1007/s12094-015-1319-6. Epub 2015 Nov 5. Clin Transl Oncol. 2016. PMID: 26542176
-
Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms.Int J Mol Sci. 2021 Oct 2;22(19):10701. doi: 10.3390/ijms221910701. Int J Mol Sci. 2021. PMID: 34639040 Free PMC article. Review.
-
Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases.Infect Dis Ther. 2014 Dec;3(2):159-74. doi: 10.1007/s40121-014-0030-1. Epub 2014 Jun 24. Infect Dis Ther. 2014. PMID: 25134687 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous